FIELD: biotechnology.
SUBSTANCE: according to the present invention the microcapsules are composed of two parts: the microcapsule membrane and the inner core; the microcapsule membrane is a polyelectrolyte composite hydrogel membrane formed from chitosan, alginates, and acyl derivatives of chitosan, and the inner core is an alginate liquid or the hydrogel medium containing cells. The method of production of the microcapsule preparation comprises mixing the microcapsules of alginate-acyl derivatives of chitosan with the aqueous solution.
EFFECT: possibility to use for encapsulation of human or mammalian cells in vitro or ex vivo.
11 cl, 3 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SORBENT FOR ANTIBODY REMOVAL FROM WHOLE BLOOD AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2360707C1 |
| METHOD FOR PREPARING MICROCAPSULES WITH LANGERHANS ISLETS AND MICROCAPSULE ACCORDING TO DISCLOSED METHOD | 2023 |
|
RU2822875C1 |
| INCAPSULATION SYSTEM | 2006 |
|
RU2429864C2 |
| METHOD OF PRODUCING ALGINATE-CHITOSAN MICROCAPSULES WITH VINPOCETINE | 2019 |
|
RU2716000C1 |
| PREORAL DELIVERY SYSTEM FOR PROTEIN SUBSTANCE (OPTIONS), PROTECTIVE COATING FOR DELIVERY SYSTEM (OPTIONS) | 2014 |
|
RU2665367C2 |
| METHOD OF PRODUCING MICROENCAPSULATED FORM OF THERAPEUTIC PROTEIN SUPEROXIDE DISMUTASE FOR ORAL APPLICATION | 2015 |
|
RU2583923C1 |
| APPLICATION OF CHITOSAN DERIVATIVE FOR SELECTIVE DELIVERY OF MEDICATIONS AND BIOLOGICALLY ACTIVE COMPLEXES | 2013 |
|
RU2561062C2 |
| DRUG FORM OF DISULFIRAM WITH PROLONGED ACTION AND METHOD OF ITS OBTAINING | 2011 |
|
RU2462235C1 |
| CHITOSAN COMPOSITION | 2008 |
|
RU2482133C2 |
| METHOD FOR DIRECTED BONE TISSUE REGENERATION | 2016 |
|
RU2620884C1 |
